News from multicell technologies, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Mar 20, 2014, 08:39 ET

MultiCell Technologies Files U.S. and International Patent Applications for the Treatment of Liver Cancer

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) has filed additional U.S. and international patent applications covering MCT-485 and its...

Jan 15, 2014, 08:39 ET

MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB) has filed a U.S. provisional patent application concerning composition of matter,...

Nov 13, 2013, 08:13 ET

MultiCell Technologies Files U.S. Patent Application for Targeted Delivery of MCT-485, a Noncoding miRNA for Cancer Treatment

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB) has filed a second U.S. patent application concerning methods and formulations to...

Oct 02, 2013, 08:00 ET

MultiCell Technologies Expands Scope of Research Agreement for the Treatment of Liver Cancer

 MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB) is pleased to announce the signing of a new sponsored research agreement with Anand...

Aug 06, 2013, 08:00 ET

MultiCell Technologies and Genisphere Evaluate Targeted Delivery of MCT-485, a Noncoding miRNA for the Treatment of Cancer

 MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) and Genisphere LLC will collaborate on the development of targeted MCT-485...

May 16, 2013, 08:00 ET

MultiCell Technologies Files U.S. Patent Application for Targeted Delivery of Noncoding Micro RNAs for the Treatment of Liver Cancer

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB) is pleased to announce the filing of a U.S. patent application concerning methods and...

Dec 26, 2012, 08:00 ET

MultiCell Technologies Delivered Presentation at 2012 ASCB Meeting

 MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) presented at the 2012 American Society for Cell Biology® (ASCB®) Annual...

Oct 22, 2012, 17:30 ET

Grant G. Miller Joins Board of MultiCell Technologies

MultiCell Technologies, Inc. (MCET.OB), a clinical-stage biopharmaceutical company, has added Grant G. Miller to its board of directors. Mr. Miller...

Sep 27, 2012, 08:00 ET

MultiCell Technologies To Announce Positive Preclinical Results at 2012 ASCB Meeting

 MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) is pleased to announce the acceptance by the American Society for Cell...

Sep 06, 2012, 13:49 ET

Scott Lukeman, Ph.D., Joins Board of MultiCell Technologies

 MultiCell Technologies, Inc. (MCET.OB), a clinical-stage biopharmaceutical company, has added Scott Lukeman, Ph.D., to its board of...

Aug 14, 2012, 12:35 ET

MultiCell Announces Results of Shareholders' Meeting

 MultiCell Technologies, Inc. (OTCBB: MCET.OB), a clinical-stage biopharmaceutical company developing novel therapeutics and discovery tools...

Aug 10, 2012, 08:00 ET

MultiCell Technologies Updates Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer in vitro Models

 MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) is pleased to announce the updated preclinical research results for MCT-465 and...

May 16, 2012, 08:00 ET

MultiCell Technologies Announces Positive Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer In Vitro Models

 MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) is pleased to announce representatives from the Company will present preclinical...

Feb 16, 2012, 08:30 ET

Xenogenics Received Rights to Polyanhydride Compounds Drug Delivery Patent

 Xenogenics Corporation, a subsidiary of MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) has exclusive license rights to a...

Jan 03, 2012, 08:30 ET

MultiCell Technologies Receives Final Payment Under QTDP Program

 MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB) has received the final cash grant award payment of $303,102 under the U.S....

Jul 11, 2011, 08:30 ET

MultiCell and University Health Network Will Evaluate Two Potential Therapies for Liver Cancer Treatment

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) ("MultiCell") today announced that it entered into a sponsored research agreement with...

May 31, 2011, 08:30 ET

MultiCell Technologies is Granted Stem Cell Patent

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) is pleased to announce the issuance of U.S. patent 7,935,528 by the United States Patent...

Nov 02, 2010, 08:00 ET

MultiCell Technologies Receives $733,437 Cash Grant Award Under U.S. Government's Qualifying Therapeutic Discovery Project Program

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB) announces it has received cash grant awards under the U.S. government's Qualifying...

Oct 19, 2010, 08:00 ET

MultiCell's Majority Owned Subsidiary Acquires Bioabsorbable Interventional Cardiology Stent Assets

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) and its majority owned subsidiary, Xenogenics Corporation, are pleased to announce the...

Aug 02, 2010, 08:00 ET

MultiCell Technologies Applies for Qualifying Therapeutic Discovery Project Grants

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) announces it has submitted four separate grant applications under the U.S. government's...